Obstetrics and gynecology
-
Obstetrics and gynecology · Mar 2019
Multicenter Study Comparative StudyOral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
To investigate the noninferiority of relugolix compared with leuprorelin acetate in reducing heavy menstrual bleeding associated with uterine leiomyomas. ⋯ Takeda Pharmaceutical Company Limited and an affiliate of NovaQuest Capital Management LLC.